Qianhai Health Holdings Limited (HKG:0911)
Hong Kong · Delayed Price · Currency is HKD 0.4100
+0.1150 (38.98%)
Apr 24, 2026, 4:08 PM HKT
Qianhai Health Holdings Revenue
In the year 2025, Qianhai Health Holdings had annual revenue of 677.12M HKD with 30.29% growth. Qianhai Health Holdings had revenue of 336.27M in the half year ending December 31, 2025, a decrease of -45.88%.
Revenue
677.12M
Revenue Growth
+30.29%
P/S Ratio
0.10
Revenue / Employee
35.64M
Employees
19
Market Cap
69.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 677.12M | 157.42M | 30.29% |
| Dec 31, 2024 | 519.70M | -441.59M | -45.94% |
| Dec 31, 2023 | 961.29M | -1.00B | -51.00% |
| Dec 31, 2022 | 1.96B | 1.68B | 592.21% |
| Dec 31, 2021 | 283.40M | -477.32M | -62.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lee's Pharmaceutical Holdings | 1.44B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.08B |
| Kontafarma China Holdings | 914.71M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| PuraPharm Corporation | 336.11M |
| Tianda Pharmaceuticals | 322.95M |
| Sanai Health Industry Group Company | 95.59M |
| Extrawell Pharmaceutical Holdings | 52.65M |